Pandox AB Series B
Pandox AB (publ), a hotel property company, owns, develops, and leases hotel properties. The company operates in two segments, Leases and Own Operations. The Leases segment leases hotels to hotel operators. The Own Operations segment owns hotel properties; and operates hotels. It has operations in Sweden, Denmark, Norway, Finland, Germany, Belgium, the United Kingdom, Ireland, and internationally… Read more
Pandox AB Series B (0R8U) - Total Assets
Latest total assets as of September 2021: Skr65.57 Billion SEK
Based on the latest financial reports, Pandox AB Series B (0R8U) holds total assets worth Skr65.57 Billion SEK as of September 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pandox AB Series B - Total Assets Trend (2016–2020)
This chart illustrates how Pandox AB Series B’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pandox AB Series B - Asset Composition Analysis
Current Asset Composition (December 2020)
Pandox AB Series B's total assets of Skr65.57 Billion consist of 5.3% current assets and 94.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0.0% |
| Accounts Receivable | Skr730.00 Million | 1.1% |
| Inventory | Skr9.00 Million | 0.0% |
| Property, Plant & Equipment | Skr60.48 Billion | 93.3% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2016–2020)
This chart illustrates how Pandox AB Series B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pandox AB Series B's current assets represent 5.3% of total assets in 2020, an increase from 2.8% in 2016.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2020, the same as 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 93.3% of total assets.
Pandox AB Series B Competitors by Total Assets
Key competitors of Pandox AB Series B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Pandox AB Series B - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Pandox AB Series B generates 0.05x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pandox AB Series B is currently not profitable relative to its asset base.
Pandox AB Series B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.21 | 0.42 | 1.06 |
| Quick Ratio | 0.21 | 0.42 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-13.89 Billion | Skr -3.83 Billion | Skr 203.00 Million |
Pandox AB Series B - Advanced Valuation Insights
This section examines the relationship between Pandox AB Series B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -1.5% |
| Total Assets | Skr64.81 Billion |
| Market Capitalization | $1.35 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Pandox AB Series B's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Pandox AB Series B's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Pandox AB Series B (2016–2020)
The table below shows the annual total assets of Pandox AB Series B from 2016 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | Skr64.81 Billion | -1.52% |
| 2019-12-31 | Skr65.81 Billion | +19.63% |
| 2018-12-31 | Skr55.02 Billion | +6.34% |
| 2017-12-31 | Skr51.74 Billion | +34.63% |
| 2016-12-31 | Skr38.43 Billion | -- |